Lexeo Therapeutics Eyes NSVT Data as Key Test for LX2020 Gene Therapy

Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an ...
PR Newswire

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use ...
Interesting Engineering

MIT team’s new software can make 3D-printed objects sense human movements

Researchers have developed software that enables 3D-printed objects to sense and respond to human movements. The system, ...